o Complications of atrial fibrillation
o Pumonary embolism
o Myocardia infarction
o Ischemic stroke
o Apsrin
Inhibits COX1 irreversibly
COX 1 enzyme involved in synthesis of platelets thromboxane A2
Adver effect: bleeding
o Clopidrogrel
Inhibits ADP blinding to platelet P2Y recepros leading to inhibitiosn of platelet activation
Oral active
Converted to active metabolite by CYP 450
Adverse effect: bleeding
Prevents ischemic stoks and heart attacks
Heparin
Administration parenteral (intravenous, and subcutaneous) does not cross membranes
Blinds to and activates antithrombin increases antithrombin activity
Used to treat acute deep bein thrombosis and pulmonary embolism
Used as preventative after myocardil infraction
o Warfarin
Mehcanims of action: Virtamin K
* Inhibits re activation of vitamin K
* Orally active
Narrow therapeutic index
Adverse effect: Bleeding – reversed by vitamin K infusion
Warfain reversal: stop warfarin, vitamin K, fresh frozen plasma, prothrombin complex conenctrate